# LIGAND PHARMACEUTICALS INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:1802d34e-867f-407f-a7a2-3e467f1bea68 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/ligand-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 19 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-29T05:23:15.160356+00:00 | | Last reviewed | 2026-10-29T05:23:15.160356+00:00 | ## Identity - Legal name: LIGAND PHARMACEUTICALS INC - Display name: LIGAND PHARMACEUTICALS INC ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-29T13:09:05.487159+00:00 | | Completeness | 0.364 | | Record Quality | 0.829 | | Directors | 8 | | Committees | 0 | | Governance events | 10 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Jason Haas: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:6 - Jason M. Aryeh: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2006-01-01. claim_id=alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:7 - John L. LaMattina: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2011-01-01. claim_id=alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:8 - John W. Kozarich: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2003-01-01. claim_id=alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:9 - Martine Zimmermann: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:10 - Nancy R. Gray: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:11 - Stephen L. Sabba: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2008-01-01. claim_id=alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:12 - Todd C. Davis: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2007-01-01. claim_id=alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:13 ## Executive leadership - Octavio Espinoza: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:14 - Todd C. Davis: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:15 ## Governance events - CFO_CHANGED: Octavio Espinoza executive of LIGAND PHARMACEUTICALS INC, effective 2026-02-27. Effective: 2026-02-27. Detected: 2026-10-29T05:23:15.160356+00:00. event_id=alpha:event:transition:1ks0en713oz0ef - CEO_CHANGED: Todd C. Davis executive of LIGAND PHARMACEUTICALS INC, effective 2026-02-27. Effective: 2026-02-27. Detected: 2026-10-29T05:23:15.160356+00:00. event_id=alpha:event:transition:3gv0771p45ljd - DIRECTOR_APPOINTED: Martine Zimmermann seat on LIGAND PHARMACEUTICALS INC, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-29T05:23:15.160356+00:00. event_id=alpha:event:transition:1bi9aug1ld734c - DIRECTOR_APPOINTED: Jason Haas seat on LIGAND PHARMACEUTICALS INC, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-29T05:23:15.160356+00:00. event_id=alpha:event:transition:145p0x61jva3x6 - DIRECTOR_APPOINTED: Nancy R. Gray seat on LIGAND PHARMACEUTICALS INC, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-29T05:23:15.160356+00:00. event_id=alpha:event:transition:199ocfi127bj0a - DIRECTOR_APPOINTED: John L. LaMattina seat on LIGAND PHARMACEUTICALS INC, effective 2011-01-01. Effective: 2011-01-01. Detected: 2026-10-29T05:23:15.160356+00:00. event_id=alpha:event:transition:1md9l3u10yo6c0 - DIRECTOR_APPOINTED: Stephen L. Sabba seat on LIGAND PHARMACEUTICALS INC, effective 2008-01-01. Effective: 2008-01-01. Detected: 2026-10-29T05:23:15.160356+00:00. event_id=alpha:event:transition:wym0frcou4af - DIRECTOR_APPOINTED: Todd C. Davis seat on LIGAND PHARMACEUTICALS INC, effective 2007-01-01. Effective: 2007-01-01. Detected: 2026-10-29T05:23:15.160356+00:00. event_id=alpha:event:transition:q0gjj1q3wunx - DIRECTOR_APPOINTED: Jason M. Aryeh seat on LIGAND PHARMACEUTICALS INC, effective 2006-01-01. Effective: 2006-01-01. Detected: 2026-10-29T05:23:15.160356+00:00. event_id=alpha:event:transition:1861d7l1qzwlfx - DIRECTOR_APPOINTED: John W. Kozarich seat on LIGAND PHARMACEUTICALS INC, effective 2003-01-01. Effective: 2003-01-01. Detected: 2026-10-29T05:23:15.160356+00:00. event_id=alpha:event:transition:1nildc016o2lp6 ## Scoped resources - `alpha://company/ligand-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record - `alpha://company/ligand-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/ligand-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/ligand-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=board - `alpha://company/ligand-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/ligand-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/ligand-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/ligand-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/ligand-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/ligand-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/ligand-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/ligand-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/ligand-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/ligand-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/ligand-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/ligand-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/ligand-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/ligand-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/ligand-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/ligand-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=events - `alpha://company/ligand-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/ligand-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/ligand-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Jason Haas: Director. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:6. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4b313794ab6309920f8e158c817430cb293e245d21cbf23246a1966afde82e40. - Jason M. Aryeh: Director. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:7. Valid from: 2006-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4b313794ab6309920f8e158c817430cb293e245d21cbf23246a1966afde82e40. - John L. LaMattina: Director. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:8. Valid from: 2011-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4b313794ab6309920f8e158c817430cb293e245d21cbf23246a1966afde82e40. - John W. Kozarich: Director. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:9. Valid from: 2003-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4b313794ab6309920f8e158c817430cb293e245d21cbf23246a1966afde82e40. - Martine Zimmermann: Director. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:10. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4b313794ab6309920f8e158c817430cb293e245d21cbf23246a1966afde82e40. - Nancy R. Gray: Director. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:11. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4b313794ab6309920f8e158c817430cb293e245d21cbf23246a1966afde82e40. - Stephen L. Sabba: Director. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:12. Valid from: 2008-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4b313794ab6309920f8e158c817430cb293e245d21cbf23246a1966afde82e40. - Todd C. Davis: Director. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:13. Valid from: 2007-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4b313794ab6309920f8e158c817430cb293e245d21cbf23246a1966afde82e40. - Octavio Espinoza: Chief Financial Officer. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:14. Valid from: 2026-02-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cf5ef2527d855f039a3a64d11699ce7785f39326397b52cb07bff869df562cd6. - Todd C. Davis: Chief Executive Officer and Director. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:leadership_role:15. Valid from: 2026-02-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d7add0fa59877e0c696f9e3f9a2fb070d6ee8b276d02f26f12db27953e857364. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - LIGAND PHARMACEUTICALS INC. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f79dc097f196caae78530949ce08c03dd818ab20f83e033d6751ec47e96b6126. ## Entity Status - Public listing published. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f79dc097f196caae78530949ce08c03dd818ab20f83e033d6751ec47e96b6126. ## Published Fact - US. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f79dc097f196caae78530949ce08c03dd818ab20f83e033d6751ec47e96b6126. - Healthcare. Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f79dc097f196caae78530949ce08c03dd818ab20f83e033d6751ec47e96b6126. ## Security Listing - LGND (NASDAQ). Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:security_listing:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f79dc097f196caae78530949ce08c03dd818ab20f83e033d6751ec47e96b6126. - LGNDZ (OTC). Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:security_listing:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f79dc097f196caae78530949ce08c03dd818ab20f83e033d6751ec47e96b6126. - LGNXZ (OTC). Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:security_listing:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f79dc097f196caae78530949ce08c03dd818ab20f83e033d6751ec47e96b6126. - LGNYZ (OTC). Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f79dc097f196caae78530949ce08c03dd818ab20f83e033d6751ec47e96b6126. - LGNZZ (OTC). Claim: alpha:claim:company:1802d34e-867f-407f-a7a2-3e467f1bea68:security_listing:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f79dc097f196caae78530949ce08c03dd818ab20f83e033d6751ec47e96b6126. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:f79dc097f196caae78530949ce08c03dd818ab20f83e033d6751ec47e96b6126: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc). - alpha:projection-evidence:document:4b313794ab6309920f8e158c817430cb293e245d21cbf23246a1966afde82e40: [DEF 14A lngd-20260421.htm](https://www.sec.gov/Archives/edgar/data/886163/000088616326000021/lngd-20260421.htm). - alpha:projection-evidence:document:cf5ef2527d855f039a3a64d11699ce7785f39326397b52cb07bff869df562cd6: [LGNDZ 10-K executive officers](https://www.sec.gov/Archives/edgar/data/886163/000088616326000006/lgnd-20251231.htm). - alpha:projection-evidence:document:d7add0fa59877e0c696f9e3f9a2fb070d6ee8b276d02f26f12db27953e857364: [LGNDZ 10-K executive officers](https://www.sec.gov/Archives/edgar/data/886163/000088616326000006/lgnd-20251231.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/ligand-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/ligand-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/ligand-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/ligand-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-29T13:09:05.219436+00:00; recorded 2026-10-29T13:09:05.219436+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.